PD-Rx Pharmaceuticals, Inc. (PDRX) Research
PD-Rx Pharmaceuticals, Inc. specializes in the pre-packaging and distribution of pharmaceutical products for the United States healthcare sector. The company supplies an extensive catalog of approximately 2,600 ready-to-dispense medications, ranging from topical treatments like creams and ointments to specialized ophthalmics, otics, oral liquids, and suspensions. In addition to its product offerings, PD-Rx provides innovative solutions like PD-Rx Net, an online platform that streamlines prescription management by enabling healthcare providers to track medications dispensed directly at the point of care and generate necessary labels for on-site filling. They also offer a practical manual dispensing system, which includes 10 record-keeping labels neatly paired with 10 bottle trays, specifically designed for convenient use by physicians who dispense prescriptions. The company further supports its clientele with professional assistance from a team of pharmacists and physicians. A key service is their pharmaceutical sampling program, which is structured to help Managed Care Organizations (MCOs) reduce medication costs, while simultaneously allowing medical professionals to offer complimentary, pre-filled prescriptions to their patients. PD-Rx Pharmaceuticals, Inc. caters to a diverse customer base, including individual physicians, retail pharmacies, and medical clinics. Established in 1986, the company is headquartered in Oklahoma City, Oklahoma.
Market snapshot
- Symbol
- PDRX
- Price
- $3.35
- Day change
- 0.00%
- Market cap
- $5.7M
- P/E ratio
- -20.10x
- 52-week range
- 2.41-3.35
- Sector
- Healthcare
- Industry
- Medical - Distribution
Peer companies
Open PD-Rx Pharmaceuticals, Inc. (PDRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.